DAVENPORT & Co LLC Has $10.02 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

DAVENPORT & Co LLC trimmed its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 9.5% in the 4th quarter, HoldingsChannel reports. The firm owned 623,306 shares of the real estate investment trust’s stock after selling 65,535 shares during the quarter. DAVENPORT & Co LLC’s holdings in Healthpeak Properties were worth $10,024,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vanderbilt University acquired a new position in shares of Healthpeak Properties in the third quarter worth about $1,263,000. Northside Capital Management LLC acquired a new stake in shares of Healthpeak Properties during the third quarter valued at approximately $6,123,000. Baird Financial Group Inc. raised its holdings in shares of Healthpeak Properties by 38.5% during the second quarter. Baird Financial Group Inc. now owns 402,466 shares of the real estate investment trust’s stock valued at $7,047,000 after acquiring an additional 111,807 shares during the period. Argent Advisors Inc. purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $1,536,000. Finally, Twin City Private Wealth LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at approximately $1,148,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

DOC stock opened at $16.81 on Thursday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82. The stock has a market cap of $11.69 billion, a P/E ratio of 168.16, a P/E/G ratio of 8.94 and a beta of 1.12. The firm has a 50 day simple moving average of $17.25 and a 200 day simple moving average of $17.53. Healthpeak Properties, Inc. has a 52 week low of $15.71 and a 52 week high of $20.52.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. The firm had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm’s revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a dividend yield of 7.3%. The ex-dividend date is Tuesday, March 17th. Healthpeak Properties’s payout ratio is currently 1,220.00%.

Analysts Set New Price Targets

DOC has been the topic of several research analyst reports. Evercore lowered their price objective on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Jefferies Financial Group lowered Healthpeak Properties from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $17.00 in a report on Monday, December 15th. Weiss Ratings raised Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. The Goldman Sachs Group assumed coverage on Healthpeak Properties in a report on Friday, January 9th. They set a “neutral” rating and a $17.00 price target on the stock. Finally, Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $19.42.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.